ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.305,57
-0,34%
S&P 500
5.304,72
0,70%
US Dollar vs BRL
5,1671
0,00%
Bitcoin
69.178,82
-0,13%
Brent Oil
81,965
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. USOTC
  6. RepliCel Life Sciences Inc (CE) (REPCF)

  7. RepliCel Life Sciences Inc (CE) (REPCF) Notícias

REPCF

RepliCel Life Sciences (CE) (REPCF)

RepliCel Life Sciences Inc (CE)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:REPCF
DataHoraFonteTítuloCódigoCompanhia
30/11/202315:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
31/05/202307:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
20/04/202314:04Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:REPCFRepliCel Life Sciences Inc (CE)
16/03/202315:40Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:REPCFRepliCel Life Sciences Inc (CE)
29/09/202207:02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:REPCFRepliCel Life Sciences Inc (CE)
13/09/202207:01Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)USOTC:REPCFRepliCel Life Sciences Inc (CE)
29/06/202207:02Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:REPCFRepliCel Life Sciences Inc (CE)
14/06/202112:47Edgar (US Regulatory)Amended Small Company Offering and Sale of Securities Without Registration (d/a)USOTC:REPCFRepliCel Life Sciences Inc (CE)
09/09/202007:01Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
07/05/201818:15Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)USOTC:REPCFRepliCel Life Sciences Inc (CE)
07/05/201813:53Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:REPCFRepliCel Life Sciences Inc (CE)
20/06/201418:00MarketwiredRepliCel Retains O&M Partners to Coordinate North American Focused Investor Marketing CampaignUSOTC:REPCFRepliCel Life Sciences Inc (CE)
17/06/201409:00MarketwiredRepliCel Life Sciences Announces Closing of Third and Final Tranche of Private PlacementUSOTC:REPCFRepliCel Life Sciences Inc (CE)
05/06/201418:14MarketwiredRepliCel Retains Christina Cameron as Canadian Investor Relations ConsultantUSOTC:REPCFRepliCel Life Sciences Inc (CE)
20/05/201409:00MarketwiredRepliCel Life Sciences' Licensing Partner, Shiseido, Opens Cell Processing & Expansion Facility in Japan to Advance RCH-01, a...USOTC:REPCFRepliCel Life Sciences Inc (CE)
11/04/201410:33Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:REPCFRepliCel Life Sciences Inc (CE)
18/03/201409:00MarketwiredRepliCel Reports 2013 Annual Financial ResultsUSOTC:REPCFRepliCel Life Sciences Inc (CE)
27/02/201410:00MarketwiredRepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress of the Japanese Society for Regenerative MedicineUSOTC:REPCFRepliCel Life Sciences Inc (CE)
26/02/201419:00MarketwiredRepliCel Retains Ubika Communication for Online Capital Market ExposureUSOTC:REPCFRepliCel Life Sciences Inc (CE)
13/01/201411:00MarketwiredRepliCel Receives Japanese Patent Covering its Hair Regeneration TechnologyUSOTC:REPCFRepliCel Life Sciences Inc (CE)
09/01/201411:00MarketwiredRepliCel to Commence Trading on the TSX Venture ExchangeUSOTC:REPCFRepliCel Life Sciences Inc (CE)
09/01/201410:50MarketwiredRepliCel Life Sciences to Present at Biotech Showcase(TM) 2014USOTC:REPCFRepliCel Life Sciences Inc (CE)
02/01/201411:00MarketwiredReplicel Announces Conditional Approval from TSX Venture ExchangeUSOTC:REPCFRepliCel Life Sciences Inc (CE)
19/12/201311:00MarketwiredRepliCel Reports Progress on Shiseido Technology Transfer for RCH-01 Treatment for Pattern BaldnessUSOTC:REPCFRepliCel Life Sciences Inc (CE)
21/05/201318:24Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:REPCFRepliCel Life Sciences Inc (CE)
12/04/201307:02Edgar (US Regulatory)Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)USOTC:REPCFRepliCel Life Sciences Inc (CE)
 Apresentando as notícias mais relevantes sobre:USOTC:REPCF

Seu Histórico Recente

BIT
F29983
Vontobel Financial Produ...
UNSW3
OPULUSDT
OpulousToken
AMEX
XVS
BIT
F05068
Vontobel
DBI
IIVA
ESG USD High Yield Corpo...
ASX
RCF
BIT
P1PLT6
BNP Paribas Issuance
USOTC
MMSBF
Megmilk Snow Brand (PK)
EU
4467T
4467T
USOTC
WEGRY
Weir (PK)
COIN
GSBLUST
GasBlock
COIN
CYLUSD
CrystalToken
ASX
IDA
Indiana Resources
CRTO
TRBUSDT
Tellor Tributes
NASDAQ
QDEL
QuidelOrtho
BOV
E1XR34M
Extra Space Storage
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados